Drug Development Linked More Closely to Diagnostics

FDA and industry discuss proposals for regulating combination diagnostics, medical devices, and pharmacogenomic-based drug products.

Related Content:

Formulation and Drug DeliveryProcess and ScalingQuality SystemsRegulatory Oversight and ComplianceDrug DevelopmentPharmaceutical Technology-10-02-2004

A CDMO’s Role in API Quality

FDA Grants Fast Track Designation to Teva Celiac Disease Candidate

GSK, Spero Therapeutics Oral UTI Treatment Trial Stopped Early for Efficacy